This study compared color appearance data for two populations of middle-aged women: (1) women using the selective estrogen receptor modulator tamoxifen as adjuvant therapy following successful treatment for early-stage breast cancer, and (2) healthy amenorrheic (peri-or post-menopausal) control subjects not using any hormonally acting medications. A 3-alternative forced-response paradigm (with "blue", "lavender", or "white" as the allowable responses) was used for assessing the perceived color of 440-nm foveal test stimuli superimposed on a larger 3.6 log td 580-nm background. In contrast to the control subjects, the majority of tamoxifen users described the test stimuli as "white", whether at threshold or slightly suprathreshold. Threshold-sensitivity measurements themselves appeared less eVective for distinguishing between subject groups. The results show that a simple color-naming procedure can reveal alterations of foveal shortwavelength-sensitive cone-mediated visual function that are common among tamoxifen users. 
Introduction
Tamoxifen is a selective estrogen receptor modulator (SERM) that is used as adjuvant therapy for early-stage breast cancer (Clemons, Danson, & Howell, 2002) . Tamoxifen is known to occasionally cause changes in visual function that lead patients to seek ophthalmologic care, whereupon conventional ophthalmoscopic techniques can reveal pathologic changes at the retina or optic nerve head (Gorin et al., 1998; NayWeld & Gorin, 1996; Noureddin et al., 1999; Pavlidis et al., 1992) . However, two studies have reported the existence of visual change that is relatively common but also relatively subtle, and that, furthermore, occurs prior to or independent of intraocular change that would be evident ophthalmoscopically at a patient's initial presentation (Eisner, Austin, & Samples, 2004a; Gorin et al., 1998) .
The Wrst study reporting subclinical visual-function change was conducted by Gorin et al. (1998) . Gorin et al. (1998) used a desaturated D-15 test and found that the color discrimination of women who had used tamoxifen for many years tended to be slightly worse than the color discrimination of women who had never used tamoxifen. They also found reduced color discrimination for former longterm tamoxifen users as well.
Subsequently, Eisner et al. (2004a) reported that tamoxifen users had changes of visual function involving the responses of short-wavelength-sensitive (SWS) cones, which are important for color vision (Calkins, 2001) . Eisner et al. (2004a) measured visual thresholds to short-wavelength test stimuli presented on yellow backgrounds that caused these visual thresholds to be mediated via the response of SWS cones. The strongest eVect occurred in the visual-Weld periphery, where long-term tamoxifen users were found to have relatively low SWS-cone-mediated sensitivity. There was evidence of alterations in visual-adaptation dynamics at the fovea, but the eVects were weak. This could mean either that (1) foveal visual response is aVected relatively little among tamoxifen users, (2) the foveal stimulus parameters were not well suited for revealing visual change among tamoxifen users, or (3) the threshold methodology was not optimal for detecting changes in foveal response.
The rationale for the study by Eisner et al. (2004a) was based on two pieces of information: (1) the inference that tamoxifen could aVect color vision, as reported by Gorin et al. (1998) , and (2) the knowledge, based on previous studies by Eisner and colleagues (Eisner, 1993; Eisner, Samples, Campbell, & CioY, 1995) , that middle-aged or elderly women sometimes describe the color appearance of shortwavelength test stimuli at threshold as white when these stimuli are presented on yellow backgrounds that lightadapt the retina. Corresponding age-related color appearance changes were found to occur only infrequently for men, who generally described these short-wavelength test stimuli as lavender in a forced-response paradigm (Eisner, 1993; Eisner et al., 1995) , consistent with an SWS cone contribution to blueness and redness (Shinomori, Spillmann, & Werner, 1999; Wei & Shevell, 1995) . These results suggested that gender-dependent color-appearance changes might reXect age-related changes in female hormonal function.
The present study took into account the results of Gorin et al. (1998) , together with the various sets of results by Eisner and colleagues (Eisner, 1993; Eisner et al., 1995 Eisner et al., , 2004a . We sought to determine whether tamoxifen users, particularly long-term tamoxifen users, were more likely than other women to perceive short-wavelength test stimuli as white when these stimuli were presented on moderately bright yellow backgrounds that caused these stimuli to be detected via SWS cones.
Thus, the present study reports the results of color-naming data obtained using the same type of forced-response paradigm used previously for revealing gender-dependent eVects (Eisner, 1993; Eisner et al., 1995) . Because women's natural menstrual cycles can inXuence SWS-cone-mediated response (Eisner, Burke, & Toomey, 2004b) , and because tamoxifen users often become amenorrheic (Mourits et al., 2001) , all data for this report were from subjects who had not experienced menses for at least 6 months at the time of testing. In addition, none of the control subjects was using any hormonally acting medications, such as oral contraceptives or estrogen replacement.
Methods

Subjects
Subjects were recruited from two populations of women ages 40-69 years old: (1) women using the standard dose of 20 mg tamoxifen daily as adjuvant therapy after successful treatment for early-stage breast cancer (tamoxifen users), and (2) healthy women not using any hormonal medications (control subjects). Tamoxifen users were assigned to one of two groups, short-term users and long-term users, according to their duration of tamoxifen use. A 2-year cutoV was used for distinguishing short-term users (62 years) from long-term users (>2 years). The choice of a 2-year cutoV was made prospectively based on previously published visual-Weld data (see Fig. 2 in Eisner et al., 2004a ) that indicated a fairly sharp delineation for tamoxifen-associated changes of SWS-cone-mediated response. We adopted a cutoV of "less than or equal to 2 years" because a 4-month gap existed between 2 years and the next highest duration of use for subjects enrolled in the present study.
All subjects met a set of criteria for excellent ocular health, which have been described previously (Eisner et al., 2004a; Eisner & Samples, 2003) . The functional criteria included 20/20-or-better acuity in the test eye and no worse than 20/25 acuity in the fellow eye, and normal color vision in each eye (i.e., no more than a single minor transposition error on the D-15 test conducted under Macbeth illumination (Adams, Rodic, Husted, & Stamper, 1982) ). All tamoxifen subjects were fully active and able to carry on all pre-cancer activities without restriction. No subjects were known to have cancer at the time of testing, none of the control subjects had ever used tamoxifen, and none of the tamoxifen users was using any other hormonally acting medication.
Data are reported for 32 control subjects, 30 short-term tamoxifen users, and 24 long-term tamoxifen users. The average age of these control subjects was 57.5 (SD D 6.7) years, the average age of these short-term tamoxifen users was 54.2 (SD D 5.4) years, and the average age of these long-term tamoxifen users was 57.7 (SD D 6.9) years.
All subjects were unpaid volunteers. Most subjects responded to recruitment ads specifying the requirement of "normal reading vision (corrective lenses OK)". These ads were placed on electronic sites or in locations where breast cancer survivors speciWcally or women in general receive health information or health care. Ads were also placed in the local newspaper, and on the Oregon Health & Science University (OHSU) website for study opportunities. Some subjects were referred by subjects tested previously.
Procedures
Subject screening and other non-Maxwellian-view procedures
Screening and training procedures have been described previously (Eisner & Samples, 2003; Eisner et al., 2004a) . Additional procedures (Eisner, Incognito, Toomey, O'Malley, & Samples, 2005 ) that were conducted after the color-naming procedures are not reported here. All portions of the study adhered to the tenets in the Declaration of Helsinki and were approved by the OHSU Institutional Review Board and the OHSU Cancer Institute. Written informed consent was obtained from all subjects before testing.
Maxwellian-view threshold measurements
A series of foveal increment-threshold measurements were obtained for a series of test/background stimulus combinations. The apparatus and its calibration have been described previously (Eisner, 1986) , although an eye-piece/chin-rest assembly (Eisner & Samples, 2003; Eisner et al., 2004a) was used rather than a bite-bar for the present study.
All background stimuli were 11° diameter disks. Subjects were instructed to Wxate the center of these disks. Fixation was aided by a set of diagonal crosshairs with a 4° central gap. Test stimuli were 3° diameter disks that were centered inside the background crosshairs and squarewave modulated at 1.5 Hz with a 50% duty cycle. The test stimuli were presented continuously.
Thresholds were obtained using a method of ascending limits, in which the subject signaled when the test stimulus Wrst became visible. All threshold data for this paper were obtained for steady-state adaptation conditions, in which case the incremental step size was 0.06 log unit, and threshold was computed as the mean of four responses for each test/background stimulus combination.
Steady-state thresholds were measured on each of three diVerent 580-nm background Welds-2.0 log td, 1.6 log td, and 3.6 log td, in this order-using test wavelengths and adaptation periods described previously (Eisner & Samples, 2003) . SWS-cone-mediated thresholds were measured at 440 nm, and veriWcation of SWS-cone isolation at 440 nm was made by comparing 440-nm thresholds with 490-nm thresholds (Eisner et al., 1995) .
Maxwellian-view color-naming procedures
Immediately after the Wnal threshold setting was made for the 440-nm test stimulus on the 3.6 log td 580-nm background and before this setting was changed, subjects were asked, "If you had to choose, which of the following three colors best describes the test light: blue, lavender, or white?" After each subject gave her response, the test-stimulus illuminance was raised 0.2 log units, and the same question was asked again.
Results
This section is divided into two parts. The Wrst part reports the numbers of subjects in each group (control subjects, short-term tamoxifen users, and long-term tamoxifen users) who described the 440-nm test stimulus as "blue", "lavender", or "white" at threshold and at suprathreshold. The second part compares color-naming responses with threshold measurements of SWS-cone-mediated response.
Numbers of subjects using the diVerent color names
Of all the subjects tested, only 2 chose "blue" to best describe the threshold-level 440-nm stimulus. One of these 2 subjects was a short-term tamoxifen user, and the other was a control subject. However, because the 440-nm sensitivity for this tamoxifen user was clearly abnormal, being more than 1.5 log units below the corresponding sensitivity of every other subject tested with the 3.6 log td background, her data are excluded from all subsequent analyses. The sensitivity data for the other "blue-naming" subject did not appear to be abnormal. Nevertheless, her data likewise are excluded from further color-naming analyses, since grouping her data with the data from the other "non-white-naming" control subjects would only strengthen the results. That is, signiWcant p values would be considered even more signiWcant were this subject's data included.
The proportions of subjects who chose either "white" or "lavender" to best describe the threshold-level stimulus are shown in Fig. 1A . Among control subjects, there were 13 white-namers and 18 lavender-namers; among short-term tamoxifen users, there were 16 white-namers and 13 lavender-namers; and among long-term tamoxifen users, there were 21 white-namers and only 3 lavender-namers. The relative proportions of white-naming subjects diVered signiWcantly among the 3 groups (p D 0.001, likelihood ratio 2 D 13.24, df D 2), as assessed using a log-linear model with the interaction term omitted. By partitioning the likelihood ratio 2 statistic, G 2 (T), naturally into 2 separate components via decomposition of the original table T into 2 subtables (T 1 and T 2 ) such that
, it is possible to conclude more speciWcally (a) that the proportion of subjects who chose "white" to best describe the stimulus was signiWcantly higher for all the tamoxifen users combined than for control subjects (p D .012, likelihood ratio 2 D 6.30, df D 1) and (b) that the proportion was signiWcantly higher for longterm tamoxifen users than for short-term-tamoxifen users (p D .008, likelihood ratio 2 D 6.94, df D 1). Altogether, the results indicate that long-term tamoxifen use is associated with an increased likelihood of describing the threshold-level 440-nm stimulus as "white" in a forced-response paradigm with "lavender" as the alternative.
The results in the preceding paragraph were derived without regard for subjects' prior exposures to chemotherapy or radiation for breast cancer. However, an Fig. 1. (A) Bar graph representing the proportions of subjects who described the threshold-level 440-nm test stimulus as "lavender" (Wlled bars) or "white" (unWlled bars). Data from the two subjects (one control subject plus one short-term tamoxifen user) who described the stimulus as "blue" are omitted for this Wgure, for reasons provided in the text. Thus, the proportions are based on data from 31 control subjects, 29 short-term tamoxifen users, and 24 long-term tamoxifen users. (B) Bar graph representing the proportions of subjects who described the suprathreshold-level 440-nm test stimulus as "lavender" (Wlled bars) or "white" (unWlled bars). Data from the one subject (a control subject) who described the suprathreshold test stimulus as "blue" are omitted for this Wgure, along with data from the two subjects who described the threshold-level stimulus as "blue". Thus, the proportions are based on data from 30 control subjects, 29 short-term tamoxifen users, and 24 long-term tamoxifen users. The two subjects who described the threshold-level stimulus as "blue" each described the suprathreshold stimulus as "lavender". The overall pattern of results changed somewhat when the forced-response color-naming procedure was repeated with the test stimulus set at 0.2 log units above threshold. The color-naming results for the suprathreshold test stimulus are graphed in Fig. 1B in the same manner as the corresponding results for the threshold-level test stimulus in Fig. 1A . Data from the one subject (a control subject) who chose "blue" to best describe the suprathreshold stimulus are omitted from Fig. 1B , as are data from the 2 subjects who chose "blue" to best describe the threshold-level stimulus.
Threshold Color-Naming
The color-naming diVerences among the three subject groups were signiWcant for the suprathreshold stimulus (p D 0.012, likelihood ratio 2 D 8.83, df D 2), as they were for the threshold-level stimulus. Similarly, the proportion of subjects who chose "white" to best describe the suprathreshold stimulus was signiWcantly greater for all tamoxifen users combined than for control subjects (p D 0.004, likelihood ratio 2 D 8.50, df D 1). However, in contrast to the threshold-level results, the proportion of subjects who chose "white" to best describe the suprathreshold stimulus was not signiWcantly higher for long-term tamoxifen users than for short-term tamoxifen users (p D 0.567, likelihood ratio 2 D 0.33, df D 1.) This negative result was obtained largely because 7 short-term tamoxifen users who chose "lavender" to best describe the threshold-level 440-nm stimulus now chose "white" to best describe the suprathreshold 440-nm stimulus. There was less change among the other subject groups.
When the between-group comparisons for the suprathreshold color-naming data were broken down on the basis of prior treatment for breast cancer, only a single comparison (control subjects vs. tamoxifen users, for women not receiving radiation) was found to be even nominally signiWcant (p < 0.05), with more white-namers among the tamoxifen users. Surprisingly, all 5 lavender-naming long-term tamoxifen users had received neither chemotherapy nor radiation, whereas only 3 of the 19 white-naming long-tamoxifen users had received neither chemotherapy nor radiation. There is not enough information to determine whether this improbable result (p < 0.001) arose from a recruitment bias or from an unknown confound.
Comparisons of color-naming data with sensitivity data
Among control subjects, there appeared to be little to no systematic relation of color-naming to sensitivity. For example, when SWS-cone-mediated sensitivities for the 3.6 log td background were compared for white-namers vs. lavender-namers after age-adjustment using an analysis of covariance (ANCOVA), the resultant p values were 0.98 for the threshold-level color-naming data and 0.37 for the suprathreshold color-naming data. Similarly, there appeared to be little to no systematic relation of color-naming to the degree of background-induced desensitization. For example, consider the steady-state threshold elevation induced by increasing background illuminance from 1.6 to 3.6 log td. When the mean threshold elevations were compared for white-vs. lavender-namers using t tests (since there was little eVect of age on these threshold elevations, with r 2 D 0.02), the resultant p values were 0.33 for the threshold-level color-naming data and 0.88 for the suprathreshold-level color-naming data. The overall mean threshold elevation was 0.52 log units, averaging 0.56 and 0.50 log units for the threshold-level white-namers and the threshold-level lavender-namers, respectively.
In contrast to the results for the control subjects, visual sensitivities for the tamoxifen users were related to the color-names used for best describing the suprathreshold 440-nm stimulus. More speciWcally, the choice of suprathreshold color-name was related to diVerences in the ability of the visual system to adapt to backgrounds of diVerent illuminances. These adaptation eVects were measured using 440-nm test stimuli that were conWrmed by spectral sensitivity measurements to be detected via SWS cones on all backgrounds for all but 4 subjects. For these 4 subjects (2 tamoxifen users plus 2 control subjects), the degree of SWScone-isolation was uncertain for the dimmest background. Thus, these subjects' data have been excluded from all statistical analyses that include data obtained using this background.
The degree of threshold elevation (i.e., sensitivity reduction) that resulted from increasing the steady-state 580-nm background illuminance from 1.6 to 3.6 log td is graphed in Fig. 2 for all tamoxifen subjects. In Fig. 2A , the degree of threshold elevation is graphed as a function of the duration of tamoxifen use. In Fig. 2B , it is graphed as a function of age. Open symbols represent subjects who chose "white" to best describe the suprathreshold 440-nm test stimulus on the 3.6 log td 590-nm background, and Wlled symbols represent subjects who chose "lavender". The absence of any background-induced sensitivity loss for one subject is unusual but not unprecedented (Eisner et al., 2004b) . The 64-year-old subject with the excessively high degree of backgroundinduced threshold elevation (see Fig. 2B ) was the tamoxifen user who used "blue" to best describe the threshold-level 440-nm test stimulus. Even with her data omitted from the statistical comparison (since her SWS-cone response may not have been isolated for the 1.6 log td background), tamoxifen users who chose "white" to best describe the suprathreshold stimulus had a signiWcantly lower degree of backgroundinduced threshold elevation than tamoxifen users who chose "lavender" to best describe this stimulus (p D 0.026, t test). A corresponding eVect that was statistically signiWcant (p D 0.026) but small (»0.1 log unit) appeared to exist for the threshold-elevation resulting from the increase of background illuminance from 1.6 to 2.0 log td.
The degree of background-induced threshold-elevation did not diVer signiWcantly across the control subjects, short-term tamoxifen users, and long-term tamoxifen users. For example, the comparison between control subjects and long-term tamoxifen users was non-signiWcant at a nominal p value equal to 0.23 (t test). The comparisons (after age correction) were weaker for threshold measurements made for any single background illuminance. These negative results can be interpreted to mean that color naming was especially eVective for revealing eVects of tamoxifen.
There was another set of negative results that was useful for interpreting the data. With a 3.6 log td 580-nm background that isolates SWS-cone-mediated response at 490 nm, the diVerence of log sensitivity between 490 and 440 nm varies linearly with lens density (Eisner, Fleming, Klein, & Mauldin, 1987) . However, there was no suggestion whatsoever that the lens densities of tamoxifen users diVered from the lens densities of control subjects. When the diVerence between the 2 groups was assessed using an ANCOVA with age as the covariant, the resultant p value equaled 0.81. (Not surprisingly, the age-eVect itself was signiWcant at p D 0.001). This negative result indicates that the color-naming diVerences between subject groups did not result from age-related ocular media diVerences (Kraft & Werner, 1999) . Similarly, the 440-nm sensitivity data obtained for 1.6 log td backgrounds (which are plausibly assumed to cause the least sensitivity loss) gave no indication that either macular pigment or lens density diVerences were important; an ANCOVA with age as the covariant yielded a signiWcance level of p D 0.96 for the overall between-group diVerence after correction for age.
Discussion
The results demonstrate that threshold measurements of SWS-cone-mediated sensitivity may have only limited ability for detecting changes in SWS-cone-mediated response that may be subjectively apparent to subjects or to patients and that, furthermore, can be used for documenting betweengroup diVerences that are highly statistically signiWcant. In addition, the results are consistent with the possibility that changes in estrogen-receptor function can aVect the response properties of SWS-cone pathways (Eisner et al., 2004b) . Estrogen receptors are present in the retina (Kobayashi, Kobayashi, Ueda, & Honda, 1998; Munaut et al., 2001; Ogueta, Schwartz, Yamashita, & Farber, 1999; Wickham et al., 2000) , but their roles for vision are unknown.
Because every tamoxifen user in our study had been diagnosed with hormone-positive breast cancer, we cannot exclude the possibility that this form of breast cancer (or a subtype of this form of breast cancer) led to an increased tendency towards white-naming or shared a common antecedent with this tendency. In other words, the data for this study cannot logically distinguish an inherent disease-related eVect from a medication eVect. However, we prefer the latter possibility, as it is consistent with the rationale for the study and several additional pieces of information. In particular, about 13% of tamoxifen users claim to experience vision changes that they attribute to tamoxifen and that are strongly related to serum tamoxifen levels and serum tamoxifen-metabolite levels (Gallicchio et al., 2004) . In addition, the duration-of-use eVects we report are consistent with evidence for the ability of tamoxifen to alter estrogen-receptor function within the customary 5-year period of tamoxifen use (Ali & Coombes, 2002; Ring & Dowsett, 2004) . Nevertheless, because tamoxifen is almost always administered after breast cancer has been diagnosed, the confound between the breast-cancer history The threshold elevation at 440-nm caused by raising the illuminance of the steady-state 580-nm background stimulus from 1.6 to 3.6 log td, plotted as function of the duration of tamoxifen use. Open symbols represent subjects who chose "white" to best describe the suprathreshold 440-nm test stimulus, and Wlled symbols represent subjects who chose "lavender". (B) Same as (A), except that the independent variable is age rather than the duration of tamoxifen use. and the use of tamoxifen remains diYcult to disentangle directly. An alternative strategy may be to investigate the eVects of a closely related medication that can be studied prospectively using non-correlational techniques. The fertility medication clomiphene meets these criteria, as (a) it is a SERM with a chemical structure very similar to that of tamoxifen (Baker & JaVe, 1996) , (b) it may cause reversible visual disturbances (including prolonged afterimages) in up to 10% of patients under non-laboratory conditions (Fraunfelder & Fraunfelder, 2001) , and (c) it is administered electively to healthy women for a 5-day period (Baker & JaVe, 1996) . Empirically, the greatest background-induced threshold elevations among tamoxifen users were found to occur mostly among those subjects who described the suprathreshold 440-nm stimulus as "lavender". However, the degree of background-induced threshold elevation would be expected to be greatest for those subjects experiencing the greatest degree of background-induced response polarization in a spectrally opponent SWS cone pathway (Felius & Swanson, 2003; Pugh & Mollon, 1979) . For a yellow background, which increases LWS/MWS cone stimulation, the direction of polarization (the L/M direction) would be opposite to the direction of polarization (the S direction) resulting from increased SWS cone stimulation in response to a 440-nm test. Thus, the response in the S direction to the suprathreshold 440-nm stimulus may often have been greatest for those subjects for whom the response in the L/M direction to the 580-nm background stimulus also was greatest. If so, the gain and/or timing of responses in a spectrally opponent SWS cone pathway may have been altered. Subsequent studies can be designed to assess the role that hormonal change or hormonal conditions may have for the shortterm dynamics of SWS-cone-mediated response (Shapiro, Beere, & Zaidi, 2003) or for the diVerence between on-and oV-responses to SWS cone stimulation (Klug, Herr, Ngo, Sterling, & Schein, 2003; McLellan & Eskew, 2000; Shinomori et al., 1999; Vassilev, Mihaylova, Racheva, Zlatkova, & Anderson, 2003) .
